Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Non-Small Cell Lung Cancer - Study Published in the Journal of Clinical Oncology REPORTS PHASE II efficacy and safety DATA of FIGITUMUMAB (CP-751,871) In patients with non-small cell lung cancer Results Support Ongoing Phase III AD
Targacept, Inc. - Targacept Announces Positive Top-Line Results From Phase II Study of AZD3480 in Adult ADHD
Arthritis - Findings from University of Leuven broaden understanding of arthritis
Cancer - Data on cancer reported by S. Zanardi and co-researchers
Cancer - Reports from University of California describe recent advances in cancer
Cancer - Researchers from National Cancer Institute discuss findings in cancer
Cancer - Study results from University of Michigan provide new insights into cancer
Chronic Lymphocytic Leukemia - Studies from University of Texas reveal new findings on chronic lymphocytic leukemia
Heart Failure - Studies from University of California provide new data on heart failure
Melanoma - Researchers at University of California target melanoma
Monoclonal Antibodies - Reports on monoclonal antibodies findings from D. Omahony and co-researchers provide new insights
Non-Small Cell Lung Cancer - Reports from M.M. Schittenhelm and colleagues advance knowledge in non-small cell lung cancer
Pancreatic Cancer - Studies from University of Liverpool yield new data on pancreatic cancer
Prostate Cancer - Research from G. Attard and co-authors reveals new findings on prostate cancer
Thrombocytopenic Purpura - Research findings from Columbia University update understanding of thrombocytopenic purpura
Cancer Therapy - Researchers at University Hospital target cancer therapy
Chronic Lymphocytic Leukemia Therapy - Research from Ohio State University, Department of Internal Medicine reveals new findings on chronic lymphocytic leukemia therapy
Iron Overload Prevention - Reports summarize iron overload prevention study results from American University of Beirut
Life Sciences - Research from St. George's University yields new findings on life sciences
Myeloma Therapy - Research from J.R. Berenson and co-authors reveals new findings on myeloma therapy
Alkermes - Alkermes Initiates Two New Clinical Trials of ALKS 33
Antigenics Inc. - Antigenics Reports First Quarter 2009 Financial Results
ArQule, Inc. - ArQule Reports First Quarter 2009 Financial Results
Arthritis - Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis
BioCryst Pharmaceuticals - BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
Biologics - CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
Biotech Business - Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
Burzynski Research Institute, Inc. - Burzynski Research Institute Presents Positive Results From Phase II Trials of ANP for Inoperable Brainstem Glioma at the Congress
Cancer - Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor
Cancer Vaccines - AlphaVax Announces Full Enrollment in Phase I/II Study of Active Immunotherapy in Patients with Advanced or Metastatic Cancer
Celator Pharmaceuticals - Celator Pharmaceuticals to Present at 2009 BIO International Convention
Cell Therapeutics, Inc. - Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology ASCO Annual Meeting
Celsion Corporation - Celsion’s Heat Activated Liposomal Technology to be Featured in a Keynote Address at the International Nanotech and Biotechnology Innovation Conference
GTx, Inc. - GTx, Inc. Reports First Quarter 2009 Results
Heart Bypass Surgery - Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Inhibitex, Inc. - Inhibitex Initiates Phase II Clinical Trial of FV-100 for the Treatment of Shingles
Inhibitex, Inc. - Inhibitex Reports First Quarter 2009 Financial Results
Obesity - Up to 50% off on Report - Booming Global Obesity Drug Market
Obesity and Diabetes - VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
OncoGenex Pharmaceuticals, Inc. - OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
OncoGenex Pharmaceuticals, Inc. - OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting
Oncolytics Biotech Inc. - Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
OSI Pharmaceuticals, Inc. - OSI Pharmaceuticals Provides Update on Diabetes and Obesity Clinical Programs
Parkinson Disease - Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
Pharmaceuticals - Ausio Pharmaceuticals to Present at Bio(R) 2009
Premier Inc. - Hospitals, Healthcare Providers to Save with New Premier Agreements for Clinical Modular Casework
Progenics Pharmaceuticals, Inc. - Phase 3 Clinical Study of RELISTOR Presented at American Pain Society Meeting Showed Positive Activity for the Treatment of Opioid-Induced Constipation in Chronic, Non-Cancer Pain Patients
Prostate Cancer - Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
Proteolix, Inc. - Proteolix to Present Carfilzomib Clinical Data During the 2009 ASCO Annual Meeting
